XY03-EA Tablets

· Shijiazhuang Yiling Pharmaceutical Co. Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XY03-EA Tablets, covering 2023-06-22 to 2025-01-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke [Phase 2, Phase 3]